UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017502
Receipt number R000020284
Scientific Title Comparison of clinical trajectories between diabetic nephropathy and nephrosclerosis on the KDIGO guidelines heat map
Date of disclosure of the study information 2015/05/12
Last modified on 2017/01/18 14:20:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of clinical trajectories between diabetic nephropathy and nephrosclerosis on the KDIGO guidelines heat map

Acronym

Comparison between diabetic nephropathy and nephrosclerosis

Scientific Title

Comparison of clinical trajectories between diabetic nephropathy and nephrosclerosis on the KDIGO guidelines heat map

Scientific Title:Acronym

Comparison between diabetic nephropathy and nephrosclerosis

Region

Japan


Condition

Condition

Diabetic nephropathy, Nephrosclerosis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this analysis was to investigate the differences of clinical trajectories between diabetic nephropathy and nephrosclerosis using the Kidney Disease: Improving Global Outcomes (KDIGO) heat map and the clinical characteristics between the two diseases at the initiation of RRT.

Basic objectives2

Others

Basic objectives -Others

To investigate the differences of clinical characteristics between diabetic nephropathy and nephrosclerosis at the initiation of RRT.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Initiation of RRT.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) More than 45 mL/min/1.73 m2 of eGFR at the first visit of our hospital, (2) follow up period in our hospital more than 24 months, and (3) received medical treatment by nephrologist for at least 12 months prior to RRT initiation.

Key exclusion criteria

(1) age <20 years; (2) history of severe heart failure, angina, myocardial infarction, or stroke within 3 months prior to the initiation of the RRT; (3) initiated RRT due to acute kidney injury (AKI); (4) the primary cause of CKD other than diabetic nephropathy and nephrosclerosis (i.e. glomerulonephritis and cystic disease).

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masanori Abe

Organization

Nihon University School of Medicine Itabashi Hospital

Division name

Nephrology, Hypertension and Endocrinology

Zip code


Address

30-1, Oyaguchi Kami-chou, Itabshi-ku, Tokyo, Japan

TEL

03-3972-8111

Email

mabe@med.nihon-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masanori Abe

Organization

Nihon University School of Medicine

Division name

Nephrology, Hypertension and Endocrinology

Zip code


Address

30-1, Oyaguchi Kami-chou, Itabashi-ku, Tokyo, 173-8610, Japan

TEL

03-3972-8111

Homepage URL


Email

mabe@med.nihon-u.ac.jp


Sponsor or person

Institute

Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 31 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

In the present study, conducted between January 2011 and December 2013, was performed to compare the clinical progression course of diabetic nephropathy and nephrosclerosis on the heat map according to the prognosis of CKD by GFR and albuminuria category in "KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease".Subjects who were initiated renal replacement therapy in our hospital between January 2011 and December 2013 were enrolled in the present study. The data were collected by the medical record.


Management information

Registered date

2015 Year 05 Month 11 Day

Last modified on

2017 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020284


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name